4.5 Article

Spatial and temporal risk as drivers for adoption of foot and mouth disease vaccination

Journal

VACCINE
Volume 36, Issue 33, Pages 5077-5083

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2018.06.069

Keywords

Perceived risk; Spatial risk; Temporal risk; Uncertainty; Vaccination; Foot-and-mouth disease

Funding

  1. Bill & Melinda Gates Foundation [OPP1083453]
  2. Paul G. Allen School for Global Animal Health
  3. Biotechnology and Biological Sciences Research Council (BBSRC)
  4. Department for International Development
  5. Scottish Government through the Combating Infectious Diseases of Livestock for International Development initiative [BB/H009302/1]
  6. Merck Animal Health
  7. Bill and Melinda Gates Foundation [OPP1083453] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

Identifying the drivers of vaccine adoption decisions under varying levels of perceived disease risk and benefit provides insight into what can limit or enhance vaccination uptake. To address the relationship of perceived benefit relative to temporal and spatial risk, we surveyed 432 pastoralist households in northern Tanzania on vaccination for foot-and-mouth disease (FMD). Unlike human health vaccination decisions where beliefs regarding adverse, personal health effects factor heavily into perceived risk, decisions for animal vaccination focus disproportionately on dynamic risks to animal productivity. We extended a commonly used stated preference survey methodology, willingness to pay, to elicit responses for a routine vaccination strategy applied biannually and an emergency strategy applied in reaction to spatially variable, hypothetical outbreaks. Our results show that households place a higher value on vaccination as perceived risk and household capacity to cope with resource constraints increase, but that the episodic and unpredictable spatial and temporal spread of FMD contributes to increased levels of uncertainty regarding the benefit of vaccination. In addition, concerns regarding the performance of the vaccine underlie decisions for both routine and emergency vaccination, indicating a need for within community messaging and documentation of the household and population level benefits of FMD vaccination. (C) 2018 The Authors. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available